Observational Trial of Deep Learning Model for Head and Neck Cancer Prognosis
Summary
NIH registered NCT07532928, an observational study developing a dynamic deep learning model using multimodal patient data to assess prognostic risk and recommend individualized adjuvant treatment for locally advanced head and neck squamous cell carcinoma. The model aims to assist clinicians in precision therapy decisions. The study is observational with an estimated enrollment of 500 participants, registered April 16, 2026.
What changed
NIH registered a new observational clinical trial on ClinicalTrials.gov under NCT07532928. The study will develop a bidirectional deep learning model using multimodal data to assess prognostic risk in patients with locally advanced head and neck squamous cell carcinoma and recommend individualized postoperative adjuvant treatment or follow-up regimens. The study aims to achieve precision therapy and provide scientific evidence for adjuvant therapy selection decisions.
This registry entry is informational and does not create immediate compliance obligations for regulated entities. Healthcare organizations and research institutions monitoring clinical trial pipelines for competitive intelligence or research collaboration opportunities may track this study. Patients and clinical investigators can access detailed protocol information through ClinicalTrials.gov using NCT07532928. The registry entry itself does not impose new regulatory requirements on any party.
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data
Observational NCT07532928 Kind: OBSERVATIONAL Apr 16, 2026
Abstract
Based on multimodal data, we establish a dynamic deep learning model to conduct prognostic risk assessment for patients and recommend the 'most suitable' treatment/follow-up regimen after radical treatment, assisting clinicians in improving homogenized evaluation levels and achieving individualized precision therapy, thereby providing scientific evidence for the currently widely debated selection of postoperative adjuvant therapy in locally advanced head and neck squamous cell carcinoma patients.
Conditions: Deep Learning, Head & Neck Squamous Cell Carcinoma
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.